Mcfarland, 2000 - Google Patents
A review of the evidence of health claims for biotherapeutic agentsMcfarland, 2000
View PDF- Document ID
- 12191103801601565097
- Author
- Mcfarland L
- Publication year
- Publication venue
- Microbial ecology in health and disease
External Links
Snippet
The growing popularity of biotherapeutic agents, probiotics and dietary supplements has lead to a variety of different types of health claims for these agents. Because these preparations are not as closely regulated as prescription or over-the-counter drugs, health …
- 230000036541 health 0 title abstract description 30
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2300/00—Bifidobacterium
- A23Y2300/55—Longum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2220/00—Lactobacillus
- A23Y2220/73—Rhamnosus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mcfarland | A review of the evidence of health claims for biotherapeutic agents | |
| Mercenier et al. | Probiotics as biotherapeutic agents: present knowledge and future prospects | |
| Brown et al. | Probiotics and medical nutrition therapy | |
| Mercenier et al. | Probiotics as biotherapeutic agents: present knowledge and future prospects | |
| Parracho et al. | Probiotics and prebiotics in infant nutrition | |
| Gill et al. | Probiotics and human health: a clinical perspective | |
| Chen et al. | Probiotics and prebiotics: role in clinical disease states | |
| ES2447572T3 (en) | Probiotics, secretory IgA and inflammation | |
| Andersson et al. | Health effects of probiotics and prebiotics A literature review on human studies | |
| Saxelin | Lactobacillus GG—a human probiotic strain with thorough clinical documentation | |
| Drisko et al. | Probiotics in health maintenance and disease prevention | |
| CA2257077C (en) | Treatment of diarrhea | |
| Sanders | Lactic acid bacteria as promoters of human health | |
| ES2265331T3 (en) | USE OF (BIFIDOBACTERIUM) IN THE TREATMENT OF INFLAMMATORY DISEASES. | |
| AU2001231746C1 (en) | Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response | |
| US20100166721A1 (en) | Probotic compositions and uses thereof | |
| US20110165127A1 (en) | Dairy-derived probiotic compositions and uses thereof | |
| AU2001231746A1 (en) | Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response | |
| JP7126004B2 (en) | Composition and use thereof | |
| Kolida et al. | Gastrointestinal microflora: probiotics | |
| Ozkan et al. | Effect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune response | |
| Ahmad et al. | Therapeutic aspects of probiotics and prebiotics | |
| AU2008310961B2 (en) | Probiotics for use in relieving symptoms associated with gastrointestinal disorders | |
| WO2017114900A1 (en) | Fermented formula with non-digestible oligosaccharides | |
| Vijaya Kumar et al. | Beneficial effects of probiotics and prebiotics on human health |